Adrenal Glands pp 189-194 | Cite as

Extra-adrenal and Malignant Pheochromocytoma

  • Gerard M. Doherty


Malignant Pheochromocytoma Ectopic Site Adrenal Pheochromocytoma Biochemical Diagnosis Pheochromocytoma Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Averbuch SD, et al. (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Int Med 109:267–73PubMedGoogle Scholar
  2. 2.
    Eisenhofer G (2003) Editorial: biochemical diagnosis of pheochromocytoma — is it time to switch to plasma-free metanephrines? [comment]. J Clin Endocrinol Metab 88:550–2CrossRefPubMedGoogle Scholar
  3. 3.
    Eisenhofer G, et al. (1999) Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. N Engl J Med 340:1872–9CrossRefPubMedGoogle Scholar
  4. 4.
    Eisenhofer G, et al. (1998) Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors. J Clin Endocrinol Metab 83:2175–85CrossRefPubMedGoogle Scholar
  5. 5.
    Kaltsas G, et al. (2001) Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metabol 86:895–902CrossRefGoogle Scholar
  6. 6.
    Loh KC, et al. (1997) The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients. J Endocrinol Invest 20:648–58PubMedGoogle Scholar
  7. 7.
    Lumachi F, et al. (1998) Extraadrenal and multiple pheochromocytomas. Are there really any differences in pathophysiology and outcome? J Exp Clin Cancer Res 17:303–5PubMedGoogle Scholar
  8. 8.
    Miskulin J, et al. (2003) Is preoperative iodine 123 metaiodobenzyl guanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma? Surgery 134:918–22CrossRefPubMedGoogle Scholar
  9. 9.
    Nakabeppu Y, Nakajo M (1994) Radionuclide therapy of malignant pheochromocytoma with 131I-MIBG. Ann Nucl Med 8:259–268PubMedGoogle Scholar
  10. 10.
    Pommier RF, et al. (1993) Comparison of adrenal and extraadrenal pheochromocytomas. Surgery 114:1160–5; discussion 1165–6PubMedGoogle Scholar
  11. 11.
    Pujol P, et al. (1995) Metastatic pheochromocytoma with a long-term response after iodine-131 metarodobenzylguanidine therapy. Eur J Nucl Med 22:382–384CrossRefPubMedGoogle Scholar
  12. 12.
    Rao F, Keiser HR, O’Connor DT (2002) Malignant and benign pheochromocytoma: chromaffin granule transmitters and the response to medical and surgical treatment. Ann N Y Acad Sci 971:530–2PubMedGoogle Scholar
  13. 13.
    Sawka AM, et al. (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines [comment]. J Clin Endocrinol Metab 88:553–8CrossRefPubMedGoogle Scholar
  14. 14.
    Sisson JC, et al. (1999) Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy. Am J Clin Oncol 22:364–70CrossRefPubMedGoogle Scholar
  15. 15.
    Stenstrom G, Svardsudd K (1986) Pheochromocytoma in Sweden 1958–1981. An analysis of the National Cancer Registry Data. Acta Medica Scand 220:225–32Google Scholar
  16. 16.
    Tada K, Okuda Y, Yamashita K (1998) Three cases of malignant pheochromocytoma treated with cyclophosphamide, vincristine, and dacarbazine combination chemotherapy and alpha-methyl-p-tyrosine to control hypercatecholaminemia. Horm Res 49:295–7CrossRefPubMedGoogle Scholar
  17. 17.
    Thrasher JB, et al. (1993) Pheochromocytoma of urinary bladder: contemporary methods of diagnosis and treatment options. Urology 41:435–439CrossRefPubMedGoogle Scholar
  18. 18.
    Velchik MG, et al. (1989) Localization of pheochromocytoma: MIBG, CT and MRI correlation. J Nucl Med 30:328–336PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Gerard M. Doherty

There are no affiliations available

Personalised recommendations